Last reviewed · How we verify
NCT04547413
STI/HIV Intervention Behavioral Intervention Program
NA trial testing STI/HIV Intervention Behavioral Intervention Program in Sexually Transmitted Infections in 155 participants. Completed in 10 March 2024.
10 March 2024
Quick facts
| Lead sponsor | Madigan Army Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 155 |
| Start date | 4 November 2020 |
| Primary completion | 10 March 2024 |
| Estimated completion | 10 March 2024 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- STI/HIV Intervention Behavioral Intervention Program
Conditions studied
- Sexually Transmitted Infections — all drugs for Sexually Transmitted Infections →
Sponsor
Madigan Army Medical Center
Who can join
Adults 18 to 30, any sex, with Sexually Transmitted Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The hypothesis is that a behavioral intervention tool adapted for the US military population will be acceptable and associated with a decrease in incident sexually transmitted infection (STI)/HIV rates and high-risk sexual behaviors, and increased self-reported condom use compared to the standard of care at the Joint Base Lewis-McChord (JBLM) Preventive Medicine clinic and the Fort Bragg Department of Public Health (part of Womack Army Medical Center).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Feasibility, acceptability, and short-term impact of a brief sexually transmitted infection intervention targeting U.S. Military personnel and family members.
Kunz A, Moodley A, Colby DJ, Soltis M, et al · · 2022 · cited 3× · PMID 35366848 · DOI 10.1186/s12889-022-13096-x
Verify or expand the search:
- PubMed search for NCT04547413
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sexually Transmitted Infections
Currently open trials in the same condition.
- NCT06043596 — Evaluation of the SafeSpace App Intervention · NA · recruiting
Other Madigan Army Medical Center trials
Trials by the same sponsor.
- NCT07335276 — Enhancing Operational Readiness With Digital Self-Managed Cognitive Behavioral Therapy for Insomnia (CBTI) · NA · not yet recruiting
- NCT05190341 — Ibuprofen Versus Ketorolac for Pain Relief During Hysterosalpingogram · Phase 4 · terminated
- NCT04704297 — Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial · Phase 4 · recruiting
- NCT04959318 — Precision Nutrition Impact on Health-Related Behavior Change · NA · completed
- NCT04556136 — Comparing a Novel Phototherapy Kiosk to Oral Vitamin D Supplementation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04547413 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Madigan Army Medical Center
- Last refreshed: 20 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04547413.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing